In this predefined substudy of the randomized controlled trial TALOS, we evaluated potential antiplatelet effects of the SSRI citalopram in ischaemic stroke patients treated with the P2Y12 inhibitor clopidogrel for prevention of recurrent stroke. The gene discussed is P2RY12; the disease is Stroke.